Your basket has

no items

What Should You Do?

The Newly Approved Drug

A new drug has recently been approved by the FDA. Two drugs within the same class have been withdrawn from the market due to safety issues, while one other drug in the class remains on the market. What should you do?
Immediately place the drug in stock.
Wait 6 months to stock the drug, to make sure it has no serious unknown risks.
Verbally counsel patients about the unknown risks of the new drug.
Require written informed consent of patients for the first 6 months.
Home page

Pharmacy Errors: Evaluation and Prevention

Description

This program is designed to educate readers on the basic elements of human error and how they apply to the practice of pharmacy. Theories of human error are discussed, followed by a discussion of factors that can influence error capture, production and prevention and error analysis techniques like Root Cause Analysis (RCA). Finally, the course concludes with a summary of main ideas in order to become more “error-aware.”

Learning Objectives

Upon completion of this activity, pharmacists will be able to:

  • Outline what errors are, how they happen, and how we can study them
  • Identify potential pharmacist and patient reactions to an error and methods to address errors with patients
  • Compare and contrast error management versus error prevention and define why both are necessary
  • List the six areas of organizational influence on error production and how they can be used to identify error-inducing conditions

Program Faculty

Kraig L. Schell, Ph.D.
Associate Professor of Psychology
Director, MS Program in Industrial-Organizational Psychology
Angelo State University
Member, Texas Tech University System

Kraig L. Schell is Associate Professor of Psychology and the director of the Masters program in Industrial-Organizational Psychology at Angelo State University in San Angelo, TX. He has a Ph.D. in psychology from the University of Cincinnati, with emphases in applied and organizational psychology. He specializes in research and consultation around issues of work and consumer safety, human error, motivation and attitudes. He is the editor of a continuing education series on psychology in pharmacy practice, has served as an expert witness in cases involving medication errors, and is the author of over 60 professional publications and presentations.

Disclosure

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational activity. Dr. Schell reports having no relevant affiliations or financial relationships to disclose.

Please note: The information and views presented in this CE activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may discuss the use of drugs and/or devices for unlabeled indications. Use of drugs and/or devices outside of labeling should be considered experimental. Participants are advised to consult and verify manufacturer product information, the professional literature and use his/her professional judgment in applying the presented information in patient care activities.


CE Accreditation

Release Date: 12-14-2009

Expiration Date: 12-14-2012

Pharmacists

ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-999-09-092-H05-P has been assigned to this knowledge-based home-study program. This program is approved for 6.0 contact hours (0.60 CEUs) in states that recognize ACPE providers. The purchase price of this program via the RxLaw website covers the cost of accreditation. Statements of credit will be issued online upon completion of the program evaluation and the post-test with a score of 70% or higher. No partial credit will be given.

 

Evaluation, Post-Test and Statement of Credit

Successful completion of an evaluation and post-test at the ProCE testing website is required to receive a statement of credit. Access to the testing web site using your RxLaw username and password occurs within 2 BUSINESS DAYS of purchasing the educational program.

This document is available in PDF format. Our price $299.00
You’ll need Adobe Reader to read this PDF document: download it here.
Copyright © 2010 RxLaw.org
All rights reserved.
Terms and Conditions   |   Privacy Policy